Healthcare provider profile · identity verified

Scott J Joyce, CRNP

Nurse Practitioner · GREENVILLE, PA · NPI 1366425829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	690	145
Lisinopril	Lisinopril	582	133
Gabapentin	Gabapentin	527	82
Levothyroxine Sodium	Levothyroxine Sodium	511	114
Omeprazole	Omeprazole	478	89
Amlodipine Besylate	Amlodipine Besylate	472	114
Pantoprazole Sodium	Pantoprazole Sodium	434	90
Metoprolol Tartrate	Metoprolol Tartrate	311	59
Metformin Hcl	Metformin Hcl	310	64
Albuterol Sulfate Hfa	Albuterol Sulfate	272	66
Meloxicam	Meloxicam	266	56
Hydrochlorothiazide	Hydrochlorothiazide	240	49
Potassium Chloride	Potassium Chloride	233	43
Losartan Potassium	Losartan Potassium	209	51
Furosemide	Furosemide	202	45
Tramadol Hcl	Tramadol Hcl	192	34
Azithromycin	Azithromycin	171	114
Pravastatin Sodium	Pravastatin Sodium	156	39
Simvastatin	Simvastatin	148	32
Metoprolol Succinate	Metoprolol Succinate	138	40
Escitalopram Oxalate	Escitalopram Oxalate	134	26
Montelukast Sodium	Montelukast Sodium	132	20
Duloxetine Hcl	Duloxetine Hcl	127	24
Ozempic	Semaglutide	127	22
Tizanidine Hcl	Tizanidine Hcl	121	21
Tamsulosin Hcl	Tamsulosin Hcl	113	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	111	25
Trulicity	Dulaglutide	111	21
Xarelto	Rivaroxaban	111	20
Fenofibrate	Fenofibrate Nanocrystallized	105	20
Metformin Hcl Er	Metformin Hcl	102	25
Ondansetron Hcl	Ondansetron Hcl	102	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	21
Zolpidem Tartrate	Zolpidem Tartrate	95	16
Trazodone Hcl	Trazodone Hcl	94	20
Citalopram Hbr	Citalopram Hydrobromide	93	19
Clopidogrel	Clopidogrel Bisulfate	89	17
Oxybutynin Chloride Er	Oxybutynin Chloride	89	14
Pregabalin	Pregabalin	85	15
Jardiance	Empagliflozin	84	24
Allopurinol	Allopurinol	81	16
Sertraline Hcl	Sertraline Hcl	80	19
Rosuvastatin Calcium	Rosuvastatin Calcium	77	21
Alendronate Sodium	Alendronate Sodium	75	21
Warfarin Sodium	Warfarin Sodium	75	12
Famotidine	Famotidine	73	15
Lorazepam	Lorazepam	73	22
Glipizide	Glipizide	72	15
Carvedilol	Carvedilol	70	15
Fluoxetine Hcl	Fluoxetine Hcl	70	20
Venlafaxine Hcl Er	Venlafaxine Hcl	70	12
Atenolol	Atenolol	67	17
Breo Ellipta	Fluticasone/Vilanterol	67	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	16
Amitriptyline Hcl	Amitriptyline Hcl	66	suppressed
Prednisone	Prednisone	61	36
Ventolin Hfa	Albuterol Sulfate	61	15
Fluticasone Propionate	Fluticasone Propionate	57	suppressed
Clonazepam	Clonazepam	56	suppressed
Glipizide Er	Glipizide	56	14
Bupropion Xl	Bupropion Hcl	55	suppressed
Eliquis	Apixaban	55	15
Fenofibrate	Fenofibrate	55	13
Ropinirole Hcl	Ropinirole Hcl	55	11
Glimepiride	Glimepiride	54	suppressed
Methylprednisolone	Methylprednisolone	53	43
Topiramate	Topiramate	53	suppressed
Ibuprofen	Ibuprofen	52	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	49	suppressed
Chlorthalidone	Chlorthalidone	48	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	47	14
Oxybutynin Chloride	Oxybutynin Chloride	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	15
Donepezil Hcl	Donepezil Hcl	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	28
Nystatin	Nystatin	37	20
Propranolol Hcl	Propranolol Hcl	37	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Benazepril Hcl	Benazepril Hcl	34	11
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Methocarbamol	Methocarbamol	31	suppressed
Baclofen	Baclofen	30	12
Clonidine Hcl	Clonidine Hcl	30	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	11
Novolog Flexpen	Insulin Aspart	29	suppressed
Amoxicillin	Amoxicillin	28	22
Fenofibrate	Fenofibrate,micronized	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Cephalexin	Cephalexin	25	21
Celecoxib	Celecoxib	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Temazepam	Temazepam	23	suppressed
Valsartan	Valsartan	23	suppressed
Fluconazole	Fluconazole	22	15
Januvia	Sitagliptin Phosphate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	11
Synthroid	Levothyroxine Sodium	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Epinephrine	Epinephrine	17	14
Ibu	Ibuprofen	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Naproxen	Naproxen	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Diazepam	Diazepam	15	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tradjenta	Linagliptin	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error